Distribuzione geografica
Continente #
NA - Nord America 2757
EU - Europa 288
AF - Africa 132
AS - Asia 75
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
SA - Sud America 2
Totale 3262
Nazione #
US - Stati Uniti d'America 2685
NG - Nigeria 132
FR - Francia 80
CA - Canada 66
IT - Italia 62
NL - Olanda 40
GB - Regno Unito 36
IL - Israele 28
DE - Germania 26
TR - Turchia 25
BE - Belgio 19
IR - Iran 11
FI - Finlandia 7
IN - India 5
UA - Ucraina 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GR - Grecia 4
PA - Panama 4
RO - Romania 3
AU - Australia 2
EU - Europa 2
ID - Indonesia 2
TT - Trinidad e Tobago 2
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CN - Cina 1
HK - Hong Kong 1
NO - Norvegia 1
PL - Polonia 1
RU - Federazione Russa 1
SE - Svezia 1
SI - Slovenia 1
TW - Taiwan 1
Totale 3262
Città #
Wilmington 849
Chandler 465
San Mateo 290
Ann Arbor 241
Leawood 170
Lawrence 143
Princeton 143
Benin City 132
Fairfield 97
Woodbridge 88
Paris 78
Toronto 59
Amsterdam 39
Boardman 31
London 28
Kocaeli 25
Milan 20
Seattle 19
Brussels 18
Monmouth Junction 16
Norwalk 15
San Diego 13
Ardabil 9
Abbiategrasso 8
Helsinki 7
Redwood City 7
Des Moines 6
Redmond 5
Andover 4
Augusta 4
Sacramento 4
Winnipeg 4
Athens 3
Barnsley 3
Cambridge 3
Clearwater 3
Frankfurt am Main 3
Henderson 3
Houston 3
Jacksonville 3
Phoenix 3
Ashburn 2
Evanston 2
Falls Church 2
Jakarta 2
Las Vegas 2
Ottawa 2
Tunapuna 2
Chicago 1
Ferrara 1
Genoa 1
Gurnee 1
Hanover 1
Hyderabad 1
Krimpen Aan Den Ijssel 1
La Canada Flintridge 1
Ljubljana 1
Mainz 1
Montréal 1
Mumbai 1
Nanjing 1
Raleigh 1
Rome 1
Roubaix 1
Santa Clara 1
Sheffield 1
Sjomarken 1
São Paulo 1
Taipei 1
Vancouver 1
York 1
Totale 3101
Nome #
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center 58
Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study 48
Biological characteristics and long-term outcomes in node-negative breast cancer 43
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 42
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 40
Gene methylation in pleural mesothelioma : Correlations with clinico-pathological features and patient’s follow-up 39
Targeted therapy for thymic epithelial tumors: a new horizon ? Review of the literature and two cases reports 39
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer 39
K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers 36
Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status 35
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival 35
Analysis of the learning curve of the surgical procedure for the treatment of thoracic disc herniation using anterolateral trans-thoracic approach with the aid of Image-Guided System (IGS) 34
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 34
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial 34
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 34
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival 33
Lung resection as salvage treatment for metastatic osteosarcoma. 32
Reproducibility of the WHO classification of thymomas: practical implications 32
Combined radiation and chemotherapy in esophageal cancer 31
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 31
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: Clinical and molecular results from a prospective study 31
Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: results of a dose-intensity study 31
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 30
Short schedule of cisplatin and vinorelbine: A dose-finding study in non-small-cell lung cancer 30
Lung resection for metastatic sarcomas: total survival from primary treatment. 29
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP) 29
Role of pathologic response after primary chemoradio-therapy and esophagectomy for predicted T3-4 N0-1 Mo Squamous carcinoma of the thoracic esophagus 29
Case 2. Mediastinal liposarcoma in a patient with previous testicular cancer 29
“La localizzazione anatomica delle micrometastasi di carcinoma mammario al linfonodo sentinella e’ predittiva dello stato della dissezione ascellare” 29
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery 28
Survival Outcomes in Malignant Pleural Mesothelioma Patients Fit for Surgery According to Type of Procedure and Completeness of Resection 28
Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer 28
Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma 28
Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease 28
Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients. 28
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients 27
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients 27
Surgical sentinel lymph node biopsy in early breast cancer. Could it be avoided by performing a preoperative staging procedure? A pilot study 27
OMEGA, A Randomized Trial of Local Ablative Therapy Vs. Conventional Treatment in Oligometastatic NSCLC - Trial in Progress 27
Molecular and cytologic analysis of sputum specimens in patients with lung cancer 27
Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: a case-report 26
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients 26
Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients 26
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 26
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications 26
Analysis Indicates Low Incremental Cost-Effectiveness Ratio for Implementation of Lung Cancer Screening in Italy 26
Protection of right pneumonectomy bronchial sutures with a pedicled thymus flap 26
Molecular and cytologic analysis of sputum specimens in patients with lung cancer 26
A Very Elderly Lung Cancer Patient: Case Report of a Long Disease Free Survival 26
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? 25
Robotic Surgery, VATS, and Open Surgery for Early Stage Lung Cancer: Comparison of Costs and Outcomes at a Single Institute 25
Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy and medical treatment in 60 patients 25
Malignant pleural mesothelioma (MPM) evaluation with C-11-methionine PET/CT before and after talc pleurodesis 25
Larynx preservino strategy in patients with squamous cell carcinoma of the cervical esophagus 25
Percutaneous Vertebral Augmentation in Metastatic Disease: State of the Art 25
Dante: A randomised trial on early diagnosis of lung cancer with low-dose spiral CT (LDCT); Initial announcement 25
Dante: A randomized study on lung cancer screening with low-dose spiral CT (LDCT): End of accrual and preliminary results 25
A video-assisted thoracoscopic technique to encircle the four pulmonary veins: A new surgical intervention for atrial fibrillation ablation 25
Non-small-cell lung cancer: Detection of mediastinal lymph node metastases by endoscopic ultrasound and CT 25
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer 25
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 24
Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer 24
Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: Result of a dose-intensity study 24
Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue 24
IRF4 Instructs Effector Treg Differentiation and Immune Suppression in Human Cancer 23
Dante: A randomized study on lung cancer screening with spiral CT. Work in progress 23
What counts more: the patient, the surgical technique, or the hospital? A multivariable analysis of factors affecting perioperative complications of pulmonary lobectomy by video-assisted thoracoscopic surgery from a large nationwide registry 23
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. 22
Surgical Procedures in the DANTE Trial, A Randomized Study of Lung Cancer Early Detection with Spiral Computed Tomography Comparative Analysis in the Screening and Control Arm 22
Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Evaluation of response to chemotherapy by quantitative assessment of standardized uptake value (SUV) 22
Lung cancer screening with spiral CT Baseline results of the randomized DANTE trial 22
Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy 22
Parametrical analyses at baseline and interim PET for response assessment and outcome definition in patients affected by malignant pleural mesothelioma (MPM) 22
Adjuvant chemotherapy following pneumonectomy for non small cell lung cancer: a multivariate survival analysis on a multicentric series of 61 patients 22
Multilevel En Bloc Spondylectomy for Tumors of the Thoracic and Lumbar Spine Is Challenging But Rewarding 22
Consolidation high-dose chemotherapy for patients with primary mediastinal nonseminomatous germ cell tumor 22
Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy 22
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations 21
Upfront high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (PBSCT) for international germ-cell cancer collaborative group (IGCCCG): Poor prognosis germ cell tumor (GCT) patients 21
Surgical treatment of synchronous colorectal liver and lung metastases: the usefulness of thoracophrenolaparotomy for single stage resection 21
Analysis of the learning curve of the surgical procedure for the treatment of thoracic disc herniation using anterolateral transthoracic approach with the aid of image-guided system 21
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer 20
Optimizing residual surgery for patients with primary extragonadal germ cell tumors 20
Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients 20
Short-schedule cisplatin andvinorelbine as induction chemotherapy in stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC) 20
Comorbidity, postoperative, morbidity and survival patients undergoing radical surgery for malignant pleural mesothelioma. 19
Pathological features of nodal micrometastases. Predict distant failure in patients affected by breast cancer. 19
Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography 19
Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres 19
Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer 18
Healing of bronchopleural fistula using a modified Dumon stent: a case report 18
Primary pulmonary meningioma: report of a case and review of the literature 18
Four-and Five-Level En Bloc Spondylectomy for Malignant Spinal Tumors 18
Robot-assisted surgery for lung cancer: State of the art and perspectives 18
Totale 2692
Categoria #
all - tutte 18355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18355

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202078 0000 00 00 00078
2020/20211599 16121315 8531 26075 3731503143
2021/2022764 60910153 63 35113 5910517635
2022/2023966 32864160159 111136 80 0000
Totale 3407